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Poor selectivity of monoclonal antibodies or polyclonal antisera can often handicap the development of radioimmunoassays for specific haptens. Monoclonal antibodies, despite early expectations,
have not provided better specificity than polyclonal antisera inmost of the cases published to date (1, 2) .
This problem can be circumvented in several ways: by an appropriate choice of coupling position (3) , by induction of immunotolerance (4), by modification of the assay conditions (5), orby selection ofspecific polyclonal populations by inununochromatography (6) .
Investigators inthe 1970sdemonstratedthata satisfactory radioimmunoassay couldbe obtainedby mixing two nonspecific antisera raised against a single hapten (7-9). The resulting assays discriminated better than single-antiserum immunoassays against undesired cross-reacting substances. However, structurally different compounds that were not recognized by single antisera displayed significant cross-reactivity when the antibodies were mixed (7 
Materials and Methods

Theory
The radioimmunoassay model used with two populations of antibodies and two ligands is similar to the method used by Feldman et al. (9) . The detection limit is were raised as described by Kohler and Milstein (11) . Five mice were injected intraperitoneally with 0.5 mL of pristane (2,6,10,14-tetramethyl-n-pentadecane; Aldrich Chemical Co., Milwaukee, WI) to stimulate production of monoclonal antibodies. One week later, the mice were inoculated intraperitoneally with clone 164-fused cells; ascites fluid was obtained two weeks later.
Anti-PGE2 monoclonal antibody was prepared as previously described (2). ProstaglandinF2,.(PGF2a) and 6-ketoPGE1, coupled to bovine gamma globulin (Sigma) by the carbodiimide method (12), were injected intradermally at multiple sites into rabbits (0.2 mg of immunogen per animal). This injection was repeated every two months, and blood was collected weekly from the central ear artery.
Polyclonal antisera to the luliberin analog LHRH-(pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly) were obtained as previously described (13). Antisera to DTrp6-LHRH were obtained by immunizing rabbits with a DTrp6-LHRH---benzoquinone-bovine serum albumin conjugate (14) .
Radioimmunoassays
The unlabeled metabolic products of cyclooxygenase pathways used for cross-reaction studies were kindly donated by Dr. J. Pike (Upjohn Co., Kalamazoo, MI). were incubated with the antibody in a total volume of 0.4 mL for 24 h at 4 #{176}C. Preimmune rabbit serum (10 mL) and 1 mL of ice-cold 1-propanol were then added to each sample and the antigen-antibody complex was separated by centrifugation at 2000 x g for 30 mm at 4#{176}C. The supernates were removed and their radioactivity was counted in a gamma counter (LKB; 1277 Gammamaster).
Results
Theoretical models were constructed to study the effects of two antibodies on assay specificity and sensitivity. Several variables were analyzed: the affinity (K12) of the cross-reactant (Ag2) for the first antibody (Ab1), the affinity (K21) of the analyte (Ag1) for the second antibody (Ab2), and the ratio of the two total antibody concentrations (Ab/Ab1). Figure 1 shows the predicted assay characteristics for different values of these variables. The assay specificity was increased for certain Ab/Ab1 ratios, without changing the detection limit. When the cross-reactivity of Ab1 with Ag2 was 100% and the cross-reactivity of Ab2 with Ag1 was 0.02%, the effective cross-reactivity of Ab1 with Ag2 in the assay was 2%, with an Ab2/Ab1 ratio of 1000 ( Figure IA) . A similar result was obtained when the cross-reactivity of Ab1 with Ag2 was 10% ( Figure 1B) . However, the model suggests that the specificity of the assay can be improved by minimizing the cross-reactivity of the second antibody with Ag1. Also, when cross-reactivity of Ab2 with Ag1 exceeded 0.02%, assay sensitivity decreased, with increasing Ab/Ab1 ratio ( Figure 1B ). In such a case, the population of the second antibody Ab2, with a low affinity for Ag1, becomes the major population. This leads to a decrease in assay specificity, because Ab2 is specific for the cross-reactant.
The theoretical analysis was tested experimentally in two different prostaglandin assays and in one peptide assay. The structures of the prostaglandins used are shown in Figure 2 . The specificities of the various antisera used are shown in Table 1. PGD2 assays were first performed with increasing concentrations of anti-PGF2,. antiserum ( Figure 3 ). The initial cross-reactivity of PGF2,. with anti-PGD2 monoclonal antibody was 140%; adding anti-PGF2,. antiserum decreased this to 41%.
A more-specific second antibody (cross-reactivity against PGE2 = 0.02%) was used in a series of PGE2 assays. The cross-reactivity of 6-ketoPGE1 was reduced 10-fold by including anti-6-ketoPGE1 polyclonal antiserum (Figure 3) .
The antisera to LHRH reacted with the C-terminus of the hormone and cross-reacted completely with DTrp6- anti-DTrp6-LHRH polyclonal antiserum ( Figure 3) . As with the PGE2 assay, there was a good correlation between experimental and theoretical data, and the assay detection limit was unchanged by the anti-DTrp6-LHRH antiserum (data not shown).
OH P'D2 PGF2 Fig. 2 . Structure of POE2, PGD2, 6-ketoPGE,, and PGF2,, Anti-PGD2
Anti-PGF2,. Fig. 3 . Theoretical (--) and experimental (-) cross-reactivity of (left) PGF2,. in a POD2 assay, (middle) 6-ketoPGE1 in a POE2
assay,and (right) DTrp#{176}-LHRH in a luliberin assay, as a function of the ratioof Ab0 to Ab1 LHRH (Table 1) . This cross-reactant was immunologically neutralized by a specific anti-DTrp6-LHRH polyclonal antiserum.
The cross-reactivity of the DTrp6-LHRH analog was decreased from 100% to 9% by adding
Discussion
Several approaches may be followed to increase radioimmunoassay specificity: mathematical radioimmunoassay simulation with various concentrations of crossreactant (9), immunoextraction of the analyte crossreactant (15) , or selective destruction of cross-reacting substances (16) .
Assay specificity can also be improved by mixing antisera to two different immunogens (8) . For steroids, e.g., dehydroepiandrosterone, this approach gives a radioimmunoassay with a lower cross-reactivity to each individual cross-reactant than that of either of the antisera used alone (7) . However, the number of crossreactants is increased.
Our study, which is an extension of this approach,
indicates that an antibody directed against a crossreactant may act as an immunosorbent in the assay medium.
A mathematical analysis can describe the evolution of assay specificity and detection limit for two antibodies (Figure 1 ): one (Ab1) directed against the compound to be assayed (Ag1), and the second (Ab2) directed against the cross-reactant (Ag2). The computer model shows that the conditions are optimal when the first antigen (Ag1) is poorly recognized by the second antibody (Ab2).
The model was developed to increase the specificity of monoclonal or polyclonal antibodies to prostaglandins. The unpredictable spatial presentation of the prostaglandin immunogens and (or) alterations of hapten in vivo have often hampered the production of highly specific antibodies (17) . Although both PGD2 and PGF2a immunogens were prepared by carboxyl condensation of the chain, they induced antibodies of different specificities. The monoclonal antibodies to PGD2 may recognize PGF2,., because the w-chain of the hapten may be masked by the carrier protein, whereas the more hydrophilic nature of the PGF2a hapten seems to make it more accessible to immunocompetent cells. Because PGF2a is one of the possible cross-reactants in the PGD2 assay, this model was chosen to test experimentally the feasibility of our method. The result, a twofold increase in specificity, is positive but is limited by the relatively high recognition of PGD2 by the polyclonal anti-PGF2a (cross-reactivity of 0.2%). The reduction of the crossreaction with 6-ketoPGE1 in the PGE2 assay is more dramatic and is due to the low recognition of PGE2 by the 6-ketoPGE1 antiserum (cross-reactivity of 0.02%). The use of two antisera in the LHRH assay was similarly effective, and here again there was a good correlation between the theoretical and experimental data. Although the model has been developed for the case of a single major cross-reactant, it may readily be extended to multiple cross-reactants. The limiting factor may be the availability of sufficient quantities of appro-priate immunosorbent antibody.
The addition of a second antibody to functionally remove the cross-reactant from the reaction medium is similar to adding excess cross-reactant to the medium to extract the antibody that binds this cross-reactant. The latter approach cannot be used in RIAs of haptens because the antibody binding the cross-reactant is often the same as the antibody binding the target hapten (18) ; however, this approach can be used in RIAs of proteins.
In conclusion, the liquid-phase immunoabsorption method presented here is easier and faster than the classical solid-phase immunoabsorbent procedure (15) , which requires that the antibodies first be chemically attached to a solid phase and that the samples be adsorbed and eluted. Mathematical modeling for describing assay characteristics is a valuable tool for optimizing assay conditions in which two antibodies are used.
